Prichard Heather Ledbetter 4
4 · Humacyte, Inc. · Filed May 26, 2023
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Prichard Heather Ledbetter
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-25$1.19/sh+64,990$77,338→ 74,179 total - Exercise/Conversion
Stock Options (right to buy)
2023-05-25−64,990→ 0 totalExercise: $1.19From: 2016-11-22Exp: 2023-11-22→ Common Stock (64,990 underlying) - Exercise/Conversion
Common Stock
2023-05-24$1.19/sh+13,789$16,409→ 22,978 total - Sale
Common Stock
2023-05-25$3.83/sh−9,613$36,818→ 64,566 total - Exercise/Conversion
Stock Options (right to buy)
2023-05-24−13,789→ 64,990 totalExercise: $1.19From: 2016-11-22Exp: 2023-11-22→ Common Stock (13,789 underlying) - Sale
Common Stock
2023-05-24$4.14/sh−13,789$57,086→ 9,189 total
Footnotes (2)
- [F1]The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.14 to $4.16. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.82 to $3.89. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.